IS DARATUMUMAB ELIMINATED IN THE URINE OF PATIENTS WITH AL AMYLOIDOSIS?

被引：0
|
作者：
Gil Alos, D. [1 ]
Cuevas Gomez, D. [2 ]
Colmenares Gil, R. [1 ]
Gil Manso, R. [1 ]
Iniguez Garcia, R. [1 ]
Zamanillo Herrero, I [1 ]
Poza Santaella, M. [1 ]
Puerta Fonolla, P. [2 ]
Sanchez Pina, J. M. [1 ]
Martinez Lopez, J. [1 ]
机构：
[1] Hosp 12 Octubre, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Hosp 12 Octubre, Serv Bioquim & Anal Clin, Madrid, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-030
引用
下载
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [41] Successful Conversion and Implementation to Subcutaneous Daratumumab in Patients with Multiple Myeloma ( MM) and Light Chain (AL) Amyloidosis
    Hughes, David
    Henshaw, Lynnette
    Blevins, Frances
    Edwards, Camille V.
    Lerner, Adam
    Sloan, John Mark
    Sanchorawala, Vaishali
    BLOOD, 2021, 138 : 1975 - +
  • [42] Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis
    Chung, Alfred
    Kaufman, Gregory P.
    Sidana, Surbhi
    Eckhert, Erik
    Schrier, Stanley
    Arai, Sally
    Lafayette, Richard
    Witteles, Ronald
    Liedtke, Michaela
    BLOOD, 2019, 134
  • [43] Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
    Palladini, Giovanni
    Kastritis, Efstathios
    Maurer, Mathew S.
    Zonder, Jeffrey
    Minnema, Monique C.
    Wechalekar, Ashutosh D.
    Jaccard, Arnaud
    Lee, Hans C.
    Bumma, Naresh
    Kaufman, Jonathan L.
    Medvedova, Eva
    Kovacsovics, Tibor
    Rosenzweig, Michael
    Sanchorawala, Vaishali
    Qin, Xiang
    Vasey, Sandra Y.
    Weiss, Brendan M.
    Vermeulen, Jessica
    Merlini, Giampaolo
    Comenzo, Raymond L.
    BLOOD, 2020, 136 (01) : 71 - 80
  • [44] A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis
    Bellofiore, Claudia
    Benvenuti, Pietro
    Mina, Roberto
    Basset, Marco
    Foli, Andrea
    Nanci, Martina
    Nuvolone, Mario
    Guida, Gianluigi
    Attanasio, Andrea
    Mussinelli, Roberta
    Mangiacavalli, Silvia
    Cartia, Claudio Salvatore
    Masoni, Valeria
    Palumbo, Michele
    Cani, Lorenzo
    Oliva, Stefania
    Consoli, Ugo
    Conticello, Concetta
    Di Raimondo, Francesco
    Arcaini, Luca
    Bringhen, Sara
    Merlini, Giampaolo
    Palladini, Giovanni
    Milani, Paolo
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [45] Pattern of Use and Efficacy of Daratumumab-Based Therapy in Patients with AL Amyloidosis: A Single Institution Experience
    Dima, Danai
    Hu, Xiao
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    BLOOD, 2020, 136
  • [46] Serum and Urine Light Chains in AL Amyloidosis
    Mead, G. P.
    Stubbs, P. D.
    Goodman, H. J. B.
    Hawkins, P. N.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S106 - S106
  • [47] EXPERIENCE WITH DARATUMUMAB IN PRIMARY AMYLOIDOSIS
    Begona, Navarro-Almenzar
    Perianes Valentin, Cabanas
    Rodriguez Marisabell, Santos
    Begona Soledad, Muina Juarez
    Peralta Adela, Periago
    Almohalla Catalina, Cava
    Maria Jose, Romero Orcajada
    HAEMATOLOGICA, 2021, 106 (10) : 151 - 151
  • [48] Safety and efficacy of daratumumab-based chemoimmunotherapy in multiple myeloma or AL amyloidosis patients with advanced renal failure
    Landau, Kevin
    Fu, Chieh Lin
    Chaulagain, Chakra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S43 - S43
  • [49] Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study
    Sanchorawala, Vaishali
    Sarosiek, Shayna
    Sloan, John Mark
    Brauneis, Dina
    Migre, Mary Ellen
    Mistark, Meredith
    Santos, Stephanie
    Fennessey, Salli
    Shelton, Anthony C.
    BLOOD, 2017, 130
  • [50] Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
    Roccatello, Dario
    Fenoglio, Roberta
    Naretto, Carla
    Baldovino, Simone
    Sciascia, Savino
    Ferro, Michela
    Rossi, Daniela
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 7
12345